Filing Details

Accession Number:
0001209191-21-057037
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-21 16:30:30
Reporting Period:
2021-09-20
Accepted Time:
2021-09-21 16:30:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1762303 Avita Medical Inc. RCEL Surgical & Medical Instruments & Apparatus (3841) 202578762
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1816242 Suzanne Crowe C/O Avita Therapeutics, Inc.
28159 Avenue Stanford, Suite 220
Valencia CA 91355
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-20 1,066 $17.08 4,112 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects 5,330 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of the Issuer's common stock and have all the rights and privileges of common stock.
  2. The purchase price was converted from A$4.72, using the exchange rate as in effect on the date of the transaction, and reflects the 5:1 consolidation ratio applied in converting CDIs to shares of the Issuer's common stock.
  3. The Reporting Person holds 20,560 CDIs, which translate into the 4,112 shares of common stock set forth above.